American Journal of Cardiology
Volume 102, Issue 9 , Pages 1151-1155 , 1 November 2008

Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)

  • Nestor Mercado, MD, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
    • ,
  • Jasper J. Brugts, MD, MSc

      Affiliations

    • Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel: +31-10-703-1528; Fax: +31-10-703-2890
    • ,
  • Joachim H. Ix, MD, MAS

      Affiliations

    • Department of Medicine, Division of Nephrology, University of California, San Francisco, California
    • ,
  • Michael G. Shlipak, MD, MPH

      Affiliations

    • Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    • Department of Epidemiology, University of California, San Francisco, California
    • Department of Biostatistics, University of California, San Francisco, California
    • Section of General Internal Medicine, VA Medical Center, San Francisco, California
    • ,
  • Simon R. Dixon, MBChB

      Affiliations

    • Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
    • ,
  • Bernard J. Gersh, MBChB, DPhil

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • ,
  • Pedro A. Lemos, MD, PhD

      Affiliations

    • Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    • ,
  • Mimi Guarneri, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
    • ,
  • Paul S. Teirstein, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
    • ,
  • William Wijns, MD, PhD

      Affiliations

    • Cardiovascular Center, O.L.V. Hospital, Aalst, Belgium
    • ,
  • Patrick W. Serruys, MD, PhD

      Affiliations

    • Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    • ,
  • Eric Boersma, PhD

      Affiliations

    • Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    • ,
  • William W. O'Neill, MD

      Affiliations

    • Leonard M. Miller School of Medicine, University of Miami, Miami, Florida

Received 15 April 2008 ,Revised 11 June 2008 ,Accepted 11 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9149(08)01137-5

doi: 10.1016/j.amjcard.2008.06.035

American Journal of Cardiology
Volume 102, Issue 9 , Pages 1151-1155 , 1 November 2008

Article Tools

* Image Usage & Resolution